Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Journey Medical (DERM) Revenue: 2020-2025

Historic Revenue for Journey Medical (DERM) over the last 5 years, with Sep 2025 value amounting to $17.6 million.

  • Journey Medical's Revenue rose 20.52% to $17.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.4 million, marking a year-over-year increase of 2.82%. This contributed to the annual value of $56.1 million for FY2024, which is 29.11% down from last year.
  • Per Journey Medical's latest filing, its Revenue stood at $17.6 million for Q3 2025, which was up 17.47% from $15.0 million recorded in Q2 2025.
  • Journey Medical's Revenue's 5-year high stood at $34.5 million during Q3 2023, with a 5-year trough of $10.7 million in Q1 2021.
  • Over the past 3 years, Journey Medical's median Revenue value was $14.9 million (recorded in 2024), while the average stood at $16.5 million.
  • In the last 5 years, Journey Medical's Revenue soared by 117.33% in 2022 and then plummeted by 57.64% in 2024.
  • Over the past 5 years, Journey Medical's Revenue (Quarterly) stood at $17.5 million in 2021, then decreased by 8.85% to $16.0 million in 2022, then dropped by 4.44% to $15.3 million in 2023, then declined by 10.73% to $13.6 million in 2024, then rose by 20.52% to $17.6 million in 2025.
  • Its Revenue was $17.6 million in Q3 2025, compared to $15.0 million in Q2 2025 and $13.1 million in Q1 2025.